Details for New Drug Application (NDA): 062888
✉ Email this page to a colleague
NDA 062888 describes PRINCIPEN, which is a drug marketed by Apothecon and Bristol Myers Squibb and is included in nine NDAs. Additional details are available on the PRINCIPEN profile page.
The generic ingredient in PRINCIPEN is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.
The generic ingredient in PRINCIPEN is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.
Summary for 062888
| Tradename: | PRINCIPEN |
| Applicant: | Apothecon |
| Ingredient: | ampicillin/ampicillin trihydrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Mar 4, 1988 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Mar 4, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
